Mlejnek P - Search Results

1

Can the assessment of ABCB1 gene expression predict its function in vitro?

Kosztyu P, Dolezel P, Vaclavikova R, Mlejnek P. Kosztyu P, et al. Among authors: mlejnek p. Eur J Haematol. 2015 Aug;95(2):150-9. doi: 10.1111/ejh.12470. Epub 2015 Jan 22. Eur J Haematol. 2015. PMID: 25323158

2

Apoptosis induced by N6-substituted derivatives of adenosine is related to intracellular accumulation of corresponding mononucleotides in HL-60 cells.

Mlejnek P, Dolezel P. Mlejnek P, et al. Toxicol In Vitro. 2005 Oct;19(7):985-90. doi: 10.1016/j.tiv.2005.06.023. Epub 2005 Sep 21. Toxicol In Vitro. 2005. PMID: 16181767

3

Cyclosporin A potentiates the cytotoxic effects of methyl methanesulphonate in HL-60 and K562 cells.

Mlejnek P, Frydrych I, Dolezel P. Mlejnek P, et al. Altern Lab Anim. 2007 Mar;35(1):79-85. doi: 10.1177/026119290703500117. Altern Lab Anim. 2007. PMID: 17411355

4

The broad-spectrum caspase inhibitor Boc-Asp-CMK induces cell death in human leukaemia cells.

Frydrych I, Mlejnek P, Dolezel P, Zoumpourlis V, Krumpochova P. Frydrych I, et al. Among authors: mlejnek p. Toxicol In Vitro. 2008 Aug;22(5):1356-60. doi: 10.1016/j.tiv.2008.02.017. Epub 2008 Mar 4. Toxicol In Vitro. 2008. PMID: 18434077 Free article.

5

Cyclosporin A sensitises Bcr-Abl positive cells to imatinib mesylate independently of P-glycoprotein expression.

Frydrych I, Mlejnek P, Dolezel P. Frydrych I, et al. Among authors: mlejnek p. Toxicol In Vitro. 2009 Dec;23(8):1482-90. doi: 10.1016/j.tiv.2009.09.001. Epub 2009 Sep 6. Toxicol In Vitro. 2009. PMID: 19735720

6

Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism.

Mlejnek P, Dolezel P. Mlejnek P, et al. Acta Physiol (Oxf). 2010 Jun;199(2):171-9. doi: 10.1111/j.1748-1716.2010.02087.x. Epub 2010 Jan 30. Acta Physiol (Oxf). 2010. PMID: 20121715

7

Halogenation of N⁶-benzyladenosine decreases its cytotoxicity in human leukemia cells.

Dolezel P, Koudelkova P, Mlejnek P. Dolezel P, et al. Among authors: mlejnek p. Toxicol In Vitro. 2010 Dec;24(8):2079-83. doi: 10.1016/j.tiv.2010.07.010. Epub 2010 Jul 15. Toxicol In Vitro. 2010. PMID: 20637856

8

Partial glutathione reductase deficiency as a cause of diverse clinical manifestations in a family with unstable hemoglobin (Hemoglobin Haná, β63(E7) His-Asn).

Mojzikova R, Dolezel P, Pavlicek J, Mlejnek P, Pospisilova D, Divoky V. Mojzikova R, et al. Among authors: mlejnek p. Blood Cells Mol Dis. 2010 Oct 15;45(3):219-22. doi: 10.1016/j.bcmd.2010.07.003. Epub 2010 Aug 9. Blood Cells Mol Dis. 2010. PMID: 20692194

9

Interactions of N-desmethyl imatinib, an active metabolite of imatinib, with P-glycoprotein in human leukemia cells.

Mlejnek P, Dolezel P, Faber E, Kosztyu P. Mlejnek P, et al. Ann Hematol. 2011 Jul;90(7):837-42. doi: 10.1007/s00277-010-1142-7. Epub 2011 Jan 12. Ann Hematol. 2011. PMID: 21225261 Clinical Trial.

10

A non-radioactive assay for precise determination of intracellular levels of imatinib and its main metabolite in Bcr-Abl positive cells.

Mlejnek P, Novak O, Dolezel P. Mlejnek P, et al. Talanta. 2011 Feb 15;83(5):1466-71. doi: 10.1016/j.talanta.2010.11.028. Epub 2010 Nov 19. Talanta. 2011. PMID: 21238737

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters